. . . . . . . . . . . . . . "Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma"@en . . . . . . "Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery"@en . . . . "klinisch onderzoek"@nl . . . . . "NCT02500797" . . . "2022-01-30T00:00:00Z"^^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "18"^^ . . . . . . . . . . . . . . . . . "Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery"@en . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . "clinical trial"@en . "Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery"@en . . . . . . . . . . . . . "ensayu cl\u00EDnicu"@ast . . . . . . . "2015-07-30T00:00:00Z"^^ . . . . . . . . . . . . . "195"^^ .